Sanofi SA (LTS:0A2V)
$ 49 0 (0%) Market Cap: 122.85 Bil Enterprise Value: 141.18 Bil PE Ratio: 28.19 PB Ratio: 1.63 GF Score: 87/100

Sanofi SA at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 04:40PM GMT
Release Date Price: $48.17 (-0.25%)
Richard Vosser
JPMorgan Chase & Co, Research Division - Senior Analyst

Good afternoon. Welcome to the 39th JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst at JPMorgan, and it gives me great pleasure to introduce Paul Hudson, CEO of Sanofi. And with him today is Arnaud Robert, the Chief Digital Officer of Sanofi.

Before I hand over to Paul, I would remind you that if you'd like to ask a question in the Q&A portion, then you can do that through the Q&A section on the website, and then I will read out your question.

With that, I'd like to say great welcome to Paul Hudson, and over to you, Paul.

Paul Hudson
Sanofi - CEO & Director

Thanks, Richard, and good morning, good afternoon to everybody. Thanks for joining. Of course, we're delighted to participate. I think we'll move directly into the presentation, if that's okay. Next slide, please.

Just to remember the forward-looking statements, I won't read it out, but I think we know what it means. If we could go to Slide 3, please. So I am

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot